Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Small cell lung cancer
Closed
Phase 2
This trial is looking at whether adding nivolumab and ipilimumab after chemoradiotherapy helps to stop small cell lung cancer coming back.
It is for people who are going to have treatment for the first time for limited stage small cell lung cancer (SCLC). Limited stage SCLC is when the cancer is in a single area that can be treated with radiotherapy. It:
is only in one lung
may be in nearby lymph nodes
It is for people who are going to have treatment with chemotherapy and radiotherapy (chemoradiotherapy).
Recruitment start: 24 July 2014
Recruitment end: 30 April 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sanjay Popat
European Thoracic Oncology Platform (ETOP)
Last reviewed: 16 May 2019
CRUK internal database number: 15383
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
